News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Gentiae Clinical Research Awarded Thorough QT Study By Biotech Industry Leader
August 9, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Gentiae Clinical Research, Inc., the leader in comprehensive cardiac assessment services, announced today the commencement of a major $1.1M thorough QT study (TQT) on behalf of a Top 10 Biotech company.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
MORE ON THIS TOPIC
Earnings
Gilead Still Hungry for Deals as HIV Portfolio Grows, Veklury Crashes
October 31, 2025
·
2 min read
·
Tristan Manalac
IPO
Evommune Joins IPO Class With Planned $160M Raise for Immuno Pipeline
October 31, 2025
·
2 min read
·
Tristan Manalac
Earnings
Lilly Walks Pricing Tightrope With Upcoming Weight Loss Pill Orforglipron
October 30, 2025
·
4 min read
·
Annalee Armstrong
Earnings
Merck Vaccine Sales Drop as US Declines Strike Another Pharma
October 30, 2025
·
1 min read
·
Dan Samorodnitsky
